Schmidt, Marcus http://orcid.org/0000-0003-1365-2414
Weyer-Elberich, Veronika
Hengstler, Jan G.
Heimes, Anne-Sophie
Almstedt, Katrin
Gerhold-Ay, Aslihan
Lebrecht, Antje
Battista, Marco J.
Hasenburg, Annette
Sahin, Ugur
Kalogeras, Konstantine T.
Kellokumpu-Lehtinen, Pirkko-Liisa
Fountzilas, George
Wirtz, Ralph M.
Joensuu, Heikki
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (NGFN project Oncoprofile, no. 01GR0816)
Article History
Received: 2 November 2017
Accepted: 9 February 2018
First Online: 26 February 2018
Ethics approval and consent to participate
: Study participants signed informed consent to allow research assays to be carried out on their tumor tissue. A review board at the Helsinki University Hospital approved the FinHER study. The clinical protocol and the companion translational research studies (HE10/97) were approved by local regulatory authorities and the Bioethics Committee of the Aristotle University of Thessaloniki School of Medicine, respectively.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.